2022 annual financial data
Vaxcyte 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -232,256,000 USD and net income was -223,485,000 USD.
Operating cash flow was -170,597,000 USD.
Get free Vaxcyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -232,256,000 USD
- Net income
- -223,485,000 USD
- Operating cash flow
- -170,597,000 USD